3 - 9 February 2018
These are links to news stories from the last week that may be of interest to people in the UK. The link beneath each item will take you to the original story.
Please note that the MS Trust did not write the original items and does not endorse their content nor any claims made in them.
To keep up to date on all the latest news, views and research on multiple sclerosis, sign up for Open Door, our free newsletter or regular email alerts
Encouraging stem cell results
Treatment with stem cells led to improvements for some people with progressive MS according to research in New York. The small study involved 20 participants who received repeated injections of mesenchymal stem cells, a different type of treatment from haematopoietic stem cell transplantation (HSCT). Eight people showed improvements in their EDSS score. This was associated with people who started with an EDSS score of 6.5 or lower. Additionally, 14 showed greater muscle strength and ten had improved bladder function. A larger trial has been approved.
Source: Tisch MS Center
MS Trust link: Stem cell therapy
Tysabri and reducing relapse risk in pregnancy
Italian research found that women on Tysabri (natalizumab) had a higher risk of relapse if they stopped their treatment before getting pregnant rather than staying on the drug up to the point where they knew they were pregnant. Miscarriage and birth defect rates for women taking Tysabri during the first trimester were in line with the general population.
Source: MedPage Today
MS Trust link: Pregnancy